Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

Associate Professor Ana Domingos reviews the identification of the hormone leptin and explores its significance in the function of immune cells in obesity.

 

Leptin resistance is the main culprit of common obesity. - Prof Domingos

Domingos mice

Associate Professor Ana Domingos trained in the laboratory of our inaugural Sir Hans Krebs Award Lecture speaker, Dr Jeffrey Friedman, where the hormone leptin, a key regulator of fat mass, was discovered. In a new review published in Nature Reviews Immunology, Prof Domingos reports how leptin was first identified and the significant advances this discovery has enabled for research into obesity.

 

The discovery of leptin represented a paradigm shift at a time when mechanistic models of obesity were restricted to voluntary control of food intake and exercise. - Prof Domingos

Prof Domingos goes on to suggest that immunometabolic models of obesity would benefit from an increased focus on the contribution of leptin.

The full review "Leptin: a missing piece in the immunometabolism puzzle" is available to read in Nature Reviews Immunology.

 

Similar stories

Mapping uncharted networks in the progression of Parkinson’s

A major new $9 million project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. The project is a collaboration between a core team of Professors Stephanie Cragg, Richard Wade-Martins, and Peter Magill at Oxford, Dr Mark Howe at Boston University and Professor Dinos Meletis at the Karolinska Institute, as well as collaborators Professor Yulong Li at Peking University and Dr Michael Lin at Stanford University.

Drug could help diabetic hearts recover after a heart attack

New research led by Associate Professor Lisa Heather has found that a drug known as molidustat, currently in clinical trials for another condition, could reduce risk of heart failure after heart attacks.

Blood bank storage can reduce ability of transfusions to treat anaemia

New research from the Swietach Group in collaboration with NHS Blood and Transplant has demonstrated that the process of storing blood in blood banks can negatively impact the function of red blood cells and consequently may reduce the effectiveness of blood transfusions, a treatment commonly used to combat anaemia.

Overlapping second messengers increase dynamic control of physiological responses

New research from the Parekh and Zaccolo groups reveals that a prototypical anchoring protein, known to be responsible for regulating several important physiological processes, also orchestrates the formation of two important universal second messengers.

Feeling tired? Here’s how the brain’s ‘hourglass’ controls your need for sleep – new research

New article on The Conversation website written by Dr Lukas Krone, Associate Professor Vladyslav Vyazovskiy and Professor Zoltán Molnár.